{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:28:12Z","timestamp":1792477692064,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T00:00:00Z","timestamp":1308268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s10571-011-9725-y","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T18:28:33Z","timestamp":1308335313000},"page":"1229-1243","source":"Crossref","is-referenced-by-count":55,"title":["Adenoviral Astrocyte-Specific Expression of BDNF in the Striata of Mice Transgenic for Huntington\u2019s Disease Delays the Onset of the Motor Phenotype"],"prefix":"10.1007","volume":"31","author":[{"given":"Leticia","family":"Arregui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Razgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,17]]},"reference":[{"key":"9725_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(98)00849-X","volume":"809","author":"Y Abiru","year":"1998","unstructured":"Abiru Y, Katoh-Semba R, Nishio C, Hatanaka H (1998) High potassium enhances secretion of neurotrophic factors from cultured astrocytes. Brain Res 809:115\u2013126","journal-title":"Brain Res"},{"key":"9725_CR2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856\u2013860","journal-title":"Nature"},{"key":"9725_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","volume":"39","author":"BL Apostol","year":"2008","unstructured":"Apostol BL, Simmons DA, Zuccato C, Illes K, Pallos J, Casale M, Conforti P, Ramos C, Roarke M, Kathuria S, Cattaneo E, Marsh JL, Thompson LM (2008) CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice. Mol Cell Neurosci 39:8\u201320","journal-title":"Mol Cell Neurosci"},{"key":"9725_CR4","first-page":"35","volume-title":"Models of neuropharmacology","author":"L Arregui","year":"2009","unstructured":"Arregui L, Segovia J (2009) Transgenic murine models for Huntington\u2019s disease. In: Lilia Rocha-Arrieta L, Granados-Soto V (eds) Models of neuropharmacology. Research Signpost, Kerala, pp 35\u201360"},{"key":"9725_CR5","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24:4250\u20134258","journal-title":"J Neurosci"},{"key":"9725_CR6","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/10430349950016393","volume":"10","author":"AP Bemelmans","year":"1999","unstructured":"Bemelmans AP, Horellou P, Pradier L, Brunet I, Colin P, Mallet J (1999) Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington\u2019s disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 10:2987\u20132997","journal-title":"Hum Gene Ther"},{"key":"9725_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/1566523034578429","volume":"3","author":"JA Benitez","year":"2003","unstructured":"Benitez JA, Segovia J (2003) Gene therapy targeting in the central nervous system. Curr Gene Ther 3:127\u2013145","journal-title":"Curr Gene Ther"},{"key":"9725_CR8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/sj.cgt.7701076","volume":"14","author":"JA Benitez","year":"2007","unstructured":"Benitez JA, Arregui L, Vergara P, Segovia J (2007) Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas. Cancer Gene Ther 14:836\u2013846","journal-title":"Cancer Gene Ther"},{"key":"9725_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200806137","volume":"183","author":"M Bergami","year":"2008","unstructured":"Bergami M, Santi S, Formaggio E, Cagnoli C, Verderio C, Blum R, Berninger B, Matteoli M, Canossa M (2008) Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes. J Cell Biol 183:213\u2013221","journal-title":"J Cell Biol"},{"key":"9725_CR10","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1074\/jbc.M606508200","volume":"282","author":"A Bogush","year":"2007","unstructured":"Bogush A, Pedrini S, Pelta-Heller J, Chan T, Yang Q, Mao Z, Sluzas E, Gieringer T, Ehrlich ME (2007) AKT and CDK5\/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro. J Biol Chem 282:7352\u20137359","journal-title":"J Biol Chem"},{"key":"9725_CR11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1523\/JNEUROSCI.14-03-01030.1994","volume":"14","author":"M Brenner","year":"1994","unstructured":"Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A (1994) GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14:1030\u20131037","journal-title":"J Neurosci"},{"key":"9725_CR12","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.0709002105","volume":"105","author":"A Buffo","year":"2008","unstructured":"Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP, Mori T, Gotz M (2008) Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc Natl Acad Sci USA 105:3581\u20133586","journal-title":"Proc Natl Acad Sci USA"},{"key":"9725_CR13","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"9725_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrn1078","volume":"4","author":"MV Chao","year":"2003","unstructured":"Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4:299\u2013309","journal-title":"Nat Rev Neurosci"},{"key":"9725_CR15","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1172\/JCI31778","volume":"117","author":"SR Cho","year":"2007","unstructured":"Cho SR, Benraiss A, Chmielnicki E, Samdani A, Economides A, Goldman SA (2007) Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease. J Clin Invest 117:2889\u20132902","journal-title":"J Clin Invest"},{"key":"9725_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0165-3806(94)00197-8","volume":"85","author":"DL Choi-Lundberg","year":"1995","unstructured":"Choi-Lundberg DL, Bohn MC (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res Dev Brain Res 85:80\u201388","journal-title":"Brain Res Dev Brain Res"},{"key":"9725_CR17","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1073\/pnas.0707842104","volume":"104","author":"V Chopra","year":"2007","unstructured":"Chopra V, Fox JH, Lieberman G, Dorsey K, Matson W, Waldmeier P, Housman DE, Kazantsev A, Young AB, Hersch S (2007) A small-molecule therapeutic lead for Huntington\u2019s disease: preclinical pharmacology and efficacy of C2-8 in the R6\/2 transgenic mouse. Proc Natl Acad Sci USA 104:16685\u201316689","journal-title":"Proc Natl Acad Sci USA"},{"key":"9725_CR18","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.0904239106","volume":"106","author":"F Cicchetti","year":"2009","unstructured":"Cicchetti F, Saporta S, Hauser RA, Parent M, Saint-Pierre M, Sanberg PR, Li XJ, Parker JR, Chu Y, Mufson EJ, Kordower JH, Freeman TB (2009) Neural transplants in patients with Huntington\u2019s disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci USA 106:12483\u201312488","journal-title":"Proc Natl Acad Sci USA"},{"key":"9725_CR19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","volume":"21","author":"E Colin","year":"2005","unstructured":"Colin E, Regulier E, Perrin V, Durr A, Brice A, Aebischer P, Deglon N, Humbert S, Saudou F (2005) Akt is altered in an animal model of Huntington\u2019s disease and in patients. Eur J Neurosci 21:1478\u20131488","journal-title":"Eur J Neurosci"},{"key":"9725_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1097-4547(20000101)59:1<39::AID-JNR6>3.0.CO;2-N","volume":"59","author":"N Cortez","year":"2000","unstructured":"Cortez N, Trejo F, Vergara P, Segovia J (2000) Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial-specific promoter elicit behavioral recovery in experimental parkinsonism. J Neurosci Res 59:39\u201346","journal-title":"J Neurosci Res"},{"key":"9725_CR21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.nbd.2008.11.004","volume":"33","author":"C Cunha","year":"2009","unstructured":"Cunha C, Angelucci A, D\u2019Antoni A, Dobrossy MD, Dunnett SB, Berardi N, Brambilla R (2009) Brain-derived neurotrophic factor (BDNF) overexpression in the forebrain results in learning and memory impairments. Neurobiol Dis 33:358\u2013368","journal-title":"Neurobiol Dis"},{"key":"9725_CR22","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.1532244100","volume":"100","author":"MA Curtis","year":"2003","unstructured":"Curtis MA, Penney EB, Pearson AG, Roon-Mom WM, Butterworth NJ, Dragunow M, Connor B, Faull RL (2003) Increased cell proliferation and neurogenesis in the adult human Huntington\u2019s disease brain. Proc Natl Acad Sci USA 100:9023\u20139027","journal-title":"Proc Natl Acad Sci USA"},{"key":"9725_CR23","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jnr.21636","volume":"86","author":"EM Denovan-Wright","year":"2008","unstructured":"Denovan-Wright EM, Attis M, Rodriguez-Lebron E, Mandel RJ (2008) Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6\/1 mice. J Neurosci Res 86:1748\u20131757","journal-title":"J Neurosci Res"},{"key":"9725_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","volume":"214","author":"ND Dey","year":"2010","unstructured":"Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2019s disease. Behav Brain Res 214:193\u2013200","journal-title":"Behav Brain Res"},{"key":"9725_CR25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866:257\u2013261","journal-title":"Brain Res"},{"key":"9725_CR26","doi-asserted-by":"crossref","first-page":"13368","DOI":"10.1523\/JNEUROSCI.2918-08.2008","volume":"28","author":"RP Galvao","year":"2008","unstructured":"Galvao RP, Garcia-Verdugo JM, Alvarez-Buylla A (2008) Brain-derived neurotrophic factor signaling does not stimulate subventricular zone neurogenesis in adult mice and rats. J Neurosci 28:13368\u201313383","journal-title":"J Neurosci"},{"key":"9725_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1078\/0065-1281-00591","volume":"103","author":"CG Garcia-Tovar","year":"2001","unstructured":"Garcia-Tovar CG, Perez A, Luna J, Mena R, Osorio B, Aleman V, Mondragon R, Mornet D, Rendon A, Hernandez JM (2001) Biochemical and histochemical analysis of 71\u00a0kDa dystrophin isoform (Dp71f) in rat brain. Acta Histochem 103:209\u2013224","journal-title":"Acta Histochem"},{"key":"9725_CR28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","volume":"105","author":"K Gharami","year":"2008","unstructured":"Gharami K, Xie Y, An JJ, Tonegawa S, Xu B (2008) Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington\u2019s disease phenotypes in mice. J Neurochem 105:369\u2013379","journal-title":"J Neurochem"},{"key":"9725_CR29","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/gt.2010.71","volume":"17","author":"A Giralt","year":"2010","unstructured":"Giralt A, Friedman HC, Caneda-Ferron B, Urban N, Moreno E, Rubio N, Blanco J, Peterson A, Canals JM, Alberch J (2010) BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington\u2019s disease. Gene Ther 17:1294\u20131308","journal-title":"Gene Ther"},{"key":"9725_CR30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1046\/j.1471-4159.2001.00538.x","volume":"78","author":"E Gratacos","year":"2001","unstructured":"Gratacos E, Perez-Navarro E, Tolosa E, Arenas E, Alberch J (2001) Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J Neurochem 78:1287\u20131296","journal-title":"J Neurochem"},{"key":"9725_CR31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227:770\u2013773","journal-title":"Science"},{"key":"9725_CR32","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509\u20132514","journal-title":"Proc Natl Acad Sci USA"},{"key":"9725_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","volume":"20","author":"MA Hickey","year":"2005","unstructured":"Hickey MA, Gallant K, Gross GG, Levine MS, Chesselet MF (2005) Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing. Neurobiol Dis 20:1\u201311","journal-title":"Neurobiol Dis"},{"key":"9725_CR34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","volume":"61","author":"E Hockly","year":"2003","unstructured":"Hockly E, Woodman B, Mahal A, Lewis CM, Bates G (2003) Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse. Brain Res Bull 61:469\u2013479","journal-title":"Brain Res Bull"},{"key":"9725_CR35","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1523\/JNEUROSCI.19-13-05409.1999","volume":"19","author":"S Ivkovic","year":"1999","unstructured":"Ivkovic S, Ehrlich ME (1999) Expression of the striatal DARPP-32\/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 19:5409\u20135419","journal-title":"J Neurosci"},{"key":"9725_CR36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nn.2505","volume":"13","author":"Y Ji","year":"2010","unstructured":"Ji Y, Lu Y, Yang F, Shen W, Tang TT, Feng L, Duan S, Lu B (2010) Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons. Nat Neurosci 13:302\u2013309","journal-title":"Nat Neurosci"},{"key":"9725_CR37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","volume":"9","author":"AP Kells","year":"2004","unstructured":"Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B (2004) AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther 9:682\u2013688","journal-title":"Mol Ther"},{"key":"9725_CR38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/(SICI)1096-9861(19971013)387:1<96::AID-CNE8>3.0.CO;2-I","volume":"387","author":"JH Kordower","year":"1997","unstructured":"Kordower JH, Chen EY, Winkler C, Fricker R, Charles V, Messing A, Mufson EJ, Wong SC, Rosenstein JM, Bjorklund A, Emerich DF, Hammang J, Carpenter MK (1997) Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington\u2019s disease. J Comp Neurol 387:96\u2013113","journal-title":"J Comp Neurol"},{"key":"9725_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00063030-200519020-00003","volume":"19","author":"YS Levy","year":"2005","unstructured":"Levy YS, Gilgun-Sherki Y, Melamed E, Offen D (2005) Therapeutic potential of neurotrophic factors in neurodegenerative diseases. BioDrugs 19:97\u2013127","journal-title":"BioDrugs"},{"key":"9725_CR40","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/hmg\/ddm360","volume":"17","author":"JC Lievens","year":"2008","unstructured":"Lievens JC, Iche M, Laval M, Faivre-Sarrailh C, Birman S (2008) AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington\u2019s disease. Hum Mol Genet 17:882\u2013894","journal-title":"Hum Mol Genet"},{"key":"9725_CR41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.phrs.2009.10.002","volume":"61","author":"ST Lim","year":"2010","unstructured":"Lim ST, Airavaara M, Harvey BK (2010) Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res 61:14\u201326","journal-title":"Pharmacol Res"},{"key":"9725_CR42","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch G, Kramar EA, Rex CS, Jia Y, Chappas D, Gall CM, Simmons DA (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington\u2019s disease. J Neurosci 27:4424\u20134434","journal-title":"J Neurosci"},{"key":"9725_CR43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"9725_CR44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","volume":"153","author":"BR Miller","year":"2008","unstructured":"Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR, Kennedy RT, Rebec GV (2008) Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington\u2019s disease phenotype in the R6\/2 mouse. Neuroscience 153:329\u2013337","journal-title":"Neuroscience"},{"key":"9725_CR45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/dbio.1994.1250","volume":"165","author":"K Mizuno","year":"1994","unstructured":"Mizuno K, Carnahan J, Nawa H (1994) Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 165:243\u2013256","journal-title":"Dev Biol"},{"key":"9725_CR46","doi-asserted-by":"crossref","first-page":"12660","DOI":"10.1074\/jbc.M008104200","volume":"276","author":"SJ Mowla","year":"2001","unstructured":"Mowla SJ, Farhadi HF, Pareek S, Atwal JK, Morris SJ, Seidah NG, Murphy RA (2001) Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 276:12660\u201312666","journal-title":"J Biol Chem"},{"key":"9725_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4886(95)90002-0","volume":"131","author":"N Nakao","year":"1995","unstructured":"Nakao N, Kokaia Z, Odin P, Lindvall O (1995) Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons. Exp Neurol 131:1\u201310","journal-title":"Exp Neurol"},{"key":"9725_CR48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainresbull.2008.10.007","volume":"78","author":"PN Pallier","year":"2009","unstructured":"Pallier PN, Drew CJ, Morton AJ (2009) The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington\u2019s disease are task- and protocol-dependent: influence of non-motor factors on locomotor function. Brain Res Bull 78:347\u2013355","journal-title":"Brain Res Bull"},{"key":"9725_CR49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(00)02082-5","volume":"862","author":"F Perez-Severiano","year":"2000","unstructured":"Perez-Severiano F, Rios C, Segovia J (2000) Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington\u2019s disease. Brain Res 862:234\u2013237","journal-title":"Brain Res"},{"key":"9725_CR50","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1471-4159.2005.03047.x","volume":"93","author":"JR Pineda","year":"2005","unstructured":"Pineda JR, Canals JM, Bosch M, Adell A, Mengod G, Artigas F, Ernfors P, Alberch J (2005) Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington\u2019s disease. J Neurochem 93:1057\u20131068","journal-title":"J Neurochem"},{"key":"9725_CR51","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.neubiorev.2009.03.004","volume":"33","author":"J Prodoehl","year":"2009","unstructured":"Prodoehl J, Corcos DM, Vaillancourt DE (2009) Basal ganglia mechanisms underlying precision grip force control. Neurosci Biobehav Rev 33:900\u2013908","journal-title":"Neurosci Biobehav Rev"},{"key":"9725_CR52","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85:5733\u20135737","journal-title":"Proc Natl Acad Sci USA"},{"key":"9725_CR53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55\u201366","journal-title":"Cell"},{"key":"9725_CR54","first-page":"197","volume-title":"The neurochemistry of neuronal death","author":"J Segovia","year":"2007","unstructured":"Segovia J, Arregui L (2007) Mechanisms of neuronal death associated to Huntington\u2019s disease. In: Massieu L, Arias C, Moran J (eds) The neurochemistry of neuronal death. Research Signpost, Kerala, pp 197\u2013222"},{"key":"9725_CR55","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1046\/j.1471-4159.1994.63041218.x","volume":"63","author":"J Segovia","year":"1994","unstructured":"Segovia J, Lawless GM, Tillakaratne NJ, Brenner M, Tobin AJ (1994) Cyclic AMP decreases the expression of a neuronal marker (GAD67) and increases the expression of an astroglial marker (GFAP) in C6 cells. J Neurochem 63:1218\u20131225","journal-title":"J Neurochem"},{"key":"9725_CR56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0304-3940(98)00042-1","volume":"242","author":"J Segovia","year":"1998","unstructured":"Segovia J, Vergara P, Brenner M (1998) Differentiation-dependent expression of transgenes in engineered astrocyte cell lines. Neurosci Lett 242:172\u2013176","journal-title":"Neurosci Lett"},{"key":"9725_CR57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(82)90344-4","volume":"245","author":"DJ Selkoe","year":"1982","unstructured":"Selkoe DJ, Salazar FJ, Abraham C, Kosik KS (1982) Huntington\u2019s disease: changes in striatal proteins reflect astrocytic gliosis. Brain Res 245:117\u2013125","journal-title":"Brain Res"},{"key":"9725_CR58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7\u201335","journal-title":"Acta Neuropathol"},{"key":"9725_CR59","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","volume":"24","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, Hannan AJ (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism. J Neurosci 24:2270\u20132276","journal-title":"J Neurosci"},{"key":"9725_CR60","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1073\/pnas.0610779104","volume":"104","author":"AD Steele","year":"2007","unstructured":"Steele AD, Jackson WS, King OD, Lindquist S (2007) The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington\u2019s and prion diseases. Proc Natl Acad Sci USA 104:1983\u20131988","journal-title":"Proc Natl Acad Sci USA"},{"key":"9725_CR61","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C, Beal MF, Jones L, Kooperberg C, Olson JM, Jones KR (2007) Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27:11758\u201311768","journal-title":"J Neurosci"},{"key":"9725_CR62","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"9725_CR63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0024-3205(99)00269-6","volume":"65","author":"F Trejo","year":"1999","unstructured":"Trejo F, Vergara P, Brenner M, Segovia J (1999) Gene therapy in a rodent model of Parkinson\u2019s disease using differentiated C6 cells expressing a GFAP-tyrosine hydroxylase transgene. Life Sci 65:483\u2013491","journal-title":"Life Sci"},{"key":"9725_CR64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"9725_CR65","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/sj.gt.3302771","volume":"13","author":"CY Wang","year":"2006","unstructured":"Wang CY, Wang S (2006) Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Gene Ther 13:1447\u20131456","journal-title":"Gene Ther"},{"key":"9725_CR66","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","volume":"30","author":"Y Xie","year":"2010","unstructured":"Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice. J Neurosci 30:14708\u201314718","journal-title":"J Neurosci"},{"key":"9725_CR67","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81:294\u2013330","journal-title":"Prog Neurobiol"},{"key":"9725_CR68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","volume":"18","author":"C Zuccato","year":"2008","unstructured":"Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E (2008) Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease. Brain Pathol 18:225\u2013238","journal-title":"Brain Pathol"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-011-9725-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-011-9725-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-011-9725-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T21:04:11Z","timestamp":1560287051000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-011-9725-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,17]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["9725"],"URL":"https:\/\/doi.org\/10.1007\/s10571-011-9725-y","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,17]]}}}